Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 36 Neoplasm Metastasis 17 Liver Neoplasms 16 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Lung Neoplasms 9 Pancreatic Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Leiomyoma 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2

Interventions

Everolimus 8 Sunitinib 7 Temozolomide 6 Octreotide 4 Fluorouracil 4 Capecitabine 4 lutetium Lu 177 dotatate 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 cabozantinib 2 Thalidomide 2 Streptozocin 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 surufatinib 1 sargramostim 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pentetreotide 1 pasireotide 1 nimotuzumab 1 napabucasin 1 motesanib diphosphate 1 montanide ISA 51 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04520932 2025-05-25

RFANET

Institut Paoli-Calmettes

Phase NA Recruiting

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡